Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

The Insight Series: AI & Digital Health with Kelly Huang

27 August 2026 · By · Wire by Fusion42

Published

27 August 2026

Topic

opportunities

◆ Sectors

AI Frontier ModelsDigital HealthMedtech

◆ Geography

United States

◆ Source

Read at advamed.org →

◆ Verified

Fusion42 · 27 August 2026 · Fusion42 review

Kelly Huang, CEO of Elucid, discusses how AI is transforming cardiovascular diagnostics by enabling non-invasive, precise analysis of plaque biology and physiology from existing coronary CT angiograms to support personalized treatment decisions.

This Wire brief sits within Fusion42's coverage of AI Frontier Models, Digital Health and Medtech.

◆ ◆ The Wire takeaway

AI is moving beyond data extraction to integrate biology and physiology into heart disease diagnosis. You can use AI-powered, non-invasive tools to offer care that truly changes physician decisions and patient outcomes.

◆ Coverage

1 source · 27 Aug 2026

◆ Related on Wire

◆ Topics

AI Frontier ModelsDigital HealthMedtechai-medicinedigital-healthcardiovascular-diagnosticspersonalised-carenon-invasive